Key Insights

Highlights

Success Rate

100% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 22 trials

Success Rate

100.0%

+13.5% vs benchmark

Late-Stage Pipeline

5%

1 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

18Total
Not Applicable (12)
P 1 (1)
P 2 (4)
P 3 (1)

Trial Status

Not Yet Recruiting9
Recruiting8
Completed3
Unknown1
Enrolling By Invitation1

Trial Success Rate

100.0%

Benchmark: 86.5%

Based on 3 completed trials

Clinical Trials (22)

Showing 20 of 20 trials
NCT06614322Phase 2Recruiting

SPENDD: Quantitative Sensory Testing and Analgesic Response for Painful Peripheral Neuropathy.

NCT06964802Not ApplicableRecruiting

The Effect of Cold Salt Water Foot Bath on the Development Of Chemotherapy-Induced Peripheral Neuropathy

NCT07142304Not ApplicableRecruitingPrimary

The Lilac Device Trial

NCT07508527Not ApplicableNot Yet Recruiting

Whole-Body Vibration on Balance, Risk of Falling and Quality of Life in Chemotherapy-Induced Peripheral Neuropathy

NCT07499882Not Yet RecruitingPrimary

Intrathecal Ziconotide in Chemotherapy Induced Peripheral Neuropathy

NCT06807294Not ApplicableRecruitingPrimary

Feasibility Testing of a Tai Chi Program for Chemotherapy-Induced Peripheral Neuropathy Treatment (TCT)

NCT07368439Not ApplicableNot Yet RecruitingPrimary

Effect of Feedback-Based Balance Training on Balance and Gait in Cancer Patients With Chemotherapy-Induced Peripheral Neuropathy

NCT07346469Not ApplicableNot Yet Recruiting

Exploring the Effects of Magnesium Ions on Peripheral Neuropathy, Serum Magnesium Ion Concentration,Sleep Quality, and Quality of Life in Patients With Colorectal Cancer Receiving Chemotherapy.

NCT07333976Phase 2Completed

o Tadalafil for Prevention of Docetaxel-Induced Peripheral Neuropathy in Prostate Cancer

NCT07319481Not ApplicableNot Yet RecruitingPrimary

Preliminary Effectiveness and Feasibility of Transcutaneous Acupoints Electrical Stimulation on Chemotherapy-induced Peripheral Neuropathy Among Children With Acute Lymphoblastic Leukemia

NCT07315334Not Yet RecruitingPrimary

Assessing Functional Impairments in Patients With Chemotherapy-Induced Peripheral Neuropathy

NCT07304401RecruitingPrimary

Evaluation of Effectiveness of Closed-loop Spinal Cord Stimulation (CL-SCS) Therapy for Treatment of Chemotherapy Induced Peripheral Neuropathy

NCT07279818Not ApplicableNot Yet RecruitingPrimary

Improving Chemotherapy Induced Peripheral Neuropathy in Children With Leukemia: A Study of Transcutaneous Acupoints Electrical Stimulation and Auricular Acupressure Interventions

NCT04715542Phase 3Not Yet RecruitingPrimary

Stibium Metallicum Praeparatum 6x Versus Placebo in the Prevention of Paclitaxel-induced Peripheral Neurotoxicity

NCT07169864Not ApplicableNot Yet Recruiting

Simple Surgical Glove Compression to Prevent Chemotherapy-Induced Peripheral Neuropathy

NCT07061769Not ApplicableEnrolling By Invitation

Helping Cancer Patients Manage Neuropathy Symptoms From Chemotherapy With a Low-Intensity, Low-Risk Cranial PEMF Device

NCT06962579Not ApplicableRecruitingPrimary

The Effect of Personalized Exercise Interventions for the Prevention of Chemotherapy-induced Peripheral Neuropathy

NCT06844409CompletedPrimary

Neoadjuvant FOLFOX Chemotherapy for Colon Cancer: Long-Term Chemotherapy-Induced Peripheral Neuropathy and Impact on Quality of Life

NCT06799351Phase 2RecruitingPrimary

Gut Microbiome Profiles in Patients with Chemotherapy-induced Neuropathy in the RCT OzoParQT (NCT06706544).

NCT06706544Phase 2RecruitingPrimary

Ozone Treatment in Paresthesia (Numbness, Tingling) Secondary to Chemotherapy-induced Peripheral Neuropathy

Scroll to load more

Research Network

Activity Timeline